Portage Biotech Inc.

Not featured in screeners

Not featured in screeners

Top insiders

Download results Settings

Allan L. Shaw

Affiliate

1 sale — total 4,754 USD

Proposed sale 3 Oct 2024

Value US$4,087,388.10 | Price 26.70 | Shares 66,171

Allan L. Shaw

Affiliate

1 sale — total 77,156 USD

Proposed sale 27 Sep 2024

Value US$2,683,435.53 | Price 304.11 | Shares 40,159

Steven Mintz

Director

2 sales — total 121,245 USD

Proposed sale 18 Sep 2024

Value US$16,788.40 | Price 16.27 | Shares 1,032

Proposed sale 18 Sep 2024

Value US$104,456.79 | Price 15.96 | Shares 6,545

Gregory Bailey

Director

1 sale — total 1,235,719 USD

Proposed sale 18 Sep 2024

Value US$1,235,718.96 | Price 17.65 | Shares 70,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-10-03	2024-10-03	PrS Proposed sale	3.3 Allan L. Shaw Affiliate	66,171 26.70 US$4,087,388	66,171	26.70	US$4,087,388
2024-09-27	2024-09-27	PrS Proposed sale	3.3 Allan L. Shaw Affiliate	40,159 304.11 US$2,683,436	40,159	304.11	US$2,683,436
2024-09-23	2024-09-18	PrS Proposed sale	Steven Mintz Director Non-Executive Director	85,218 369.55 US$3,259,143	85,218	369.55	US$3,259,143
2024-09-23	2024-09-18	PrS Proposed sale	Steven Mintz Director Non-Executive Director	6,545 15.96 US$104,457	6,545	15.96	US$104,457
2024-09-20	2024-09-18	PrS Proposed sale	3.7 Gregory Bailey Director Non-Executive Director	70,000 17.65 US$1,235,719	70,000	17.65	US$1,235,719

More insider trading research around Portage Biotech Inc.